PART II
Prempro & Premarin
Side Effects
&
Class Action Lawsuit

If you are taking Prempro or Premarin you are probably aware of the dangerous side effects. What is alarming is that the latest research shows that it is even more dangerous than previously thought.

Premarin and Prempro DANGERS in the news! Get the complete history of the whole controversy regarding HRT. 
 

Prempro Class Action Lawsuit Info below

BALA CYNWYD, Pa., July 16 /PRNewswire/ -- The following statement was
Issued today by the law firm of Schiffrin & Barroway, LLP:

Notice is hereby given that on July 11, 2002, Schiffrin & Barroway, LLP
filed a national class action lawsuit on behalf of all persons who were
prescribed the hormone replacement drug Prempro, chemically known as
conjugated estrogens/ medroxyprogesterone. As alleged in the Complaint,
Wyeth and Wyeth-Ayerst Research are named as the defendants in this
Action due to their responsibility in manufacturing, promoting, marketing, distributing and/or selling Prempro. The class action seeks to (1) inform the public that users and consumers of Prempro are at an increased risk of harm and/or death, (2) establish a medical monitoring fund so that every consumer may be tested and treated for the adverse effects of Prempro, (3)reimburse monies paid for the product, and (4) provide compensation to all victims for personal injuries and death.

Continue Reading Prempro Class Action Lawsuit below

Did you know that Premarin and Prempro are make from Horse Piss, and that the animals are treated cruely? 

Learn about ranges of normal estrogen levels.

Have you tested your Female Hormones lately?
Our Easy Home Test Kit makes it simple.  

New Study Reveals Increase In Side Effects Of Estrogen Replacement Therapy

Prempro like Premarin is a medication commonly prescribed for patients in need of Hormone replacement therapy. The drug, which falls within a category of drugs knownas progestins, contains conjugated estrogens and medroxyprogesterone acetate. Approximately three million women in the United States take Premarin and Prempro daily to replace hormones lost at menopause as a means for reducing incidence of post- menopausal symptoms such as hot flashes, night sweats and vaginal dryness. The drug first received FDA approval as a hormone replacement therapy in 1995.

Between 1993 and 1998, the Women's Health Initiative (WHI), a group
Focused on the health and welfare of postmenopausal women, enrolled more than 16,000 women in a set of clinic trials to examine, among other things, the effectof estrogen plus progestin on the prevention of heart disease and hip fractures, and any associated change in risk for breast and colon cancer. The specific drug used during the study was Prempro supplied by Wyeth andWyeth- Ayerst Research.

On May 31, 2002, an independent advisory committee charged with
Reviewing the results of the clinical trials and ensuring participant safety, recommended that the trials be stopped based on a finding of increased breast cancer risk in the estrogen plus progestin group. On

July 8, 2002, participants began receiving letters informing them about the results of the study and instructing them to stop study medications. The specific study findings for the estrogen plus progestin group compared to the placebo included a 41% increase in strokes; 29% increase in heart attacks; 22% increase in total cardiovascular disease; and 26% increase in breast cancer.

On July 9, 2002, the Journal of the American Medical Association released an expedited article concerning the WHI Prempro clinical trials. The article,originally scheduled for publication on July 17, 2002, summarizes the wide-ranging harm caused by Prempro, including the "increased risks for cardiovascular disease and invasive breast cancer," and notes that "there were more harmful than beneficial outcomes in the estrogen plus progestin group vs. the placebo group."

After the lawsuit was filed, Schiffrin & Barroway, LLP obtained a copy
of a "Dear Pharmacist" letter from Wyeth Pharmaceuticals, of Philadelphia, Pennsylvania. In the letter, Victoria Kusiak, M.D., Vice President of Clinical Affairs and North American Director for Wyeth Pharmaceuticals summarizes the findings of the WHI study and clarifies "the risks and benefits associated with combination hormone replacement therapy (HRT)." Dr. Kusiak explained that "these findings provide more specific information about the breast cancer and cardiovascular risks." Wyeth has also sent a letter to Healthcare Professionals, notifying them of the discontinuance of the WHI study in light of the increased risk of breast cancer and cardiovascular events to study participants.

If you or anyone you know has been prescribed Prempro, you/they may be
members of the class described above. Plaintiff seeks to recover damages on behalf of class members and is represented by the law firm of Schiffrin & Barroway, LLP, which has significant experience and expertise prosecuting complex class actions nationwide. For more information on Schiffrin & Barroway, please visit www.sbclasslaw.com.

CONTACT: Schiffrin & Barroway, LLP
Tobias L. Milrood, Esq.
Three Bala Plaza East, Suite 400, Bala Cynwyd, PA 19004
1-888-299-7706 (toll free) or 1-610-667-7706
Or by e-mail at info@sbclasslaw.com

Also See Part I - National Institute of Health - Prescription Estrogen Warning

Did you know that majority of the symptoms of PMS and Menopause are actually caused by a shortage of progesterone that is called "estrogen dominance syndrome" Do you have the syndrome?

Learn about Pro Estron - the #1 Doctor prescribed all natural plant based estrogen therapy